IL328906A - תרכובות כימיות ושימושיהן - Google Patents

תרכובות כימיות ושימושיהן

Info

Publication number
IL328906A
IL328906A IL328906A IL32890626A IL328906A IL 328906 A IL328906 A IL 328906A IL 328906 A IL328906 A IL 328906A IL 32890626 A IL32890626 A IL 32890626A IL 328906 A IL328906 A IL 328906A
Authority
IL
Israel
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
IL328906A
Other languages
English (en)
Inventor
Brian Thomas Jones
Chenbo Wang
Paul A Barsanti
Joshua P G Taygerly
Ivan G Shabalin
Daniel Lee Severance
Daniel W Mccauley-Walden
Jonathon S Ryan
Santosh Kumar Keshipeddy
Muzaffar Alam
Jiaming Li
Melissa Fleury
Carson Douglas Matier
Benjamin Robert Taft
Original Assignee
Ideaya Biosciences Inc
Brian Thomas Jones
Chenbo Wang
Paul A Barsanti
Joshua P G Taygerly
Ivan G Shabalin
Daniel Lee Severance
Mccauley Walden Daniel W
Jonathon S Ryan
Santosh Kumar Keshipeddy
Muzaffar Alam
Jiaming Li
Melissa Fleury
Carson Douglas Matier
Benjamin Robert Taft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ideaya Biosciences Inc, Brian Thomas Jones, Chenbo Wang, Paul A Barsanti, Joshua P G Taygerly, Ivan G Shabalin, Daniel Lee Severance, Mccauley Walden Daniel W, Jonathon S Ryan, Santosh Kumar Keshipeddy, Muzaffar Alam, Jiaming Li, Melissa Fleury, Carson Douglas Matier, Benjamin Robert Taft filed Critical Ideaya Biosciences Inc
Publication of IL328906A publication Critical patent/IL328906A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL328906A 2023-12-18 2024-12-13 תרכובות כימיות ושימושיהן IL328906A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363611649P 2023-12-18 2023-12-18
PCT/US2024/060009 WO2025136811A1 (en) 2023-12-18 2024-12-13 Chemical compounds and uses thereof

Publications (1)

Publication Number Publication Date
IL328906A true IL328906A (he) 2026-08-01

Family

ID=94341082

Family Applications (1)

Application Number Title Priority Date Filing Date
IL328906A IL328906A (he) 2023-12-18 2024-12-13 תרכובות כימיות ושימושיהן

Country Status (6)

Country Link
AR (1) AR134697A1 (he)
AU (1) AU2024408085A1 (he)
CO (1) CO2026008873A2 (he)
IL (1) IL328906A (he)
TW (1) TW202542120A (he)
WO (1) WO2025136811A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026128808A1 (en) 2024-12-13 2026-06-18 Ideaya Biosciences, Inc. Kat6 and/or kat7 inhibitors for use in methods of treating cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
EE05345B1 (et) 1999-02-10 2010-10-15 Astrazeneca Ab Kinasoliini derivaadid angiogeneesi inhibiitoritena
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
UA73993C2 (uk) 2000-06-06 2005-10-17 Астразенека Аб Хіназолінові похідні для лікування пухлин та фармацевтична композиція
KR20030014425A (ko) 2000-07-07 2003-02-17 앤지오젠 파마슈티칼스 리미티드 혈관 손상제인 콜치놀 유도체
EE200300015A (et) 2000-07-07 2004-10-15 Angiogene Pharmaceuticals Limited Kolhinooli derivaadid kui angiogeneesi inhibiitorid
EP4385989A4 (en) * 2021-08-10 2024-12-18 Jiangsu Hengrui Pharmaceuticals Co., Ltd. SULFONAMIDE DERIVATIVE, MANUFACTURING PROCESS THEREOF AND MEDICAL USE THEREOF
WO2023114710A1 (en) * 2021-12-13 2023-06-22 Aurigene Oncology Limited Fused benzoisoxazolyl compounds as kat6a inhibitors

Also Published As

Publication number Publication date
AU2024408085A1 (en) 2026-06-18
TW202542120A (zh) 2025-11-01
CO2026008873A2 (es) 2026-06-30
AR134697A1 (es) 2026-03-04
WO2025136811A1 (en) 2025-06-26